Strategic Baseby Eurostatecraft
Comprehensive European Power · financial conversion comparison

Observable financial stock is not demonstrated strategic financial mobilisation

Financial–Capital joins four existing stocks around ten Bulgarian and Polish production systems while stock, activity, programme linkage, disbursement and Strategic Effect remain distinct.

Financial stock ≠ mobilisation ≠ disbursement ≠ Strategic EffectNo score, ranking, lifecycle promotion or new constraint verdict.
Verifying five-stock synthesis…Every upstream freeze must match.
Comparative CEBP finding v0.4

The financial envelope is visible; allocation and effect are not

Loading verified finding.

StockAccumulation / erosionConversionStrategic Effect
Five-stock architecture

Five evidence stocks, three public stock products

Institutional–State and Financial–Capital are accepted evidence architectures whose public country stock products remain withheld.

Humanpublic product
Productive–Industrialpublic product
Resource–Energypublic product
Institutional–Stateevidence + conversion · product withheld
Financial–Capitalevidence + conversion · product withheld
Systems10five per country
National envelopes10context only
Finance institutions10stock observed
Programme activities1stage unresolved
Disbursements0none observed
Effect links / constraints0 / 0none established
Explanatory closure

The unknown moves downstream again

Loading verified closure result.

Country evidence depth

One Polish activity trace, no financial ranking

Counts describe the frozen evidence chain. They do not measure available capital, mobilisation capacity or country performance.

Loading country summaries…

Ten-system financial seam

The first two slots populate; the last two remain open

The MESKO agreement stays AGREEMENT OBSERVED · STAGE UNRESOLVED. It is not an authorisation, commitment, contract or disbursement claim.

Loading systems…

Stock-six reassessment

Scientific–Technological leads, but is not designated

Loading verified reassessment…

Feasibility next. No Scientific–Technological stock, producer, evidence release or public product has been opened.